CVS Health Corp. closed $34.74 short of its 52-week high ($80.75), which the company reached on March 28th.

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of ...

In a report released today, Charles Rhyee from TD Cowen maintained a Hold rating on CVS Health (CVS – Research Report), with a price target of ...

CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging ...

The latest trading session saw CVS Health (CVS) ending at $45.78, denoting a -0.09% adjustment from its last day's close. This change was narrower than the S&P 500's 1.11% loss on the day. Meanwhile, ...

The community was given a bit of a shock recently when CVS announced that it would be leaving its downtown Cumberland location on Jan. 30.

Analysts have recently evaluated CVS Health and provided 12-month price targets. The average target is $68.07, accompanied by ...

All of the commercial prescriptions dispensed at CVS pharmacies will be processed through its CostVantage reimbursement model ...

United Natural Foods Inc., buoyed by the turnaround plan it began in 2023, saw the biggest lift in value last year among ...

We recently compiled a list of the 10 Best January Dividend Stocks To Buy. In this article, we are going to take a look at ...

Just more than five years ago, the Minnesota Legislature attempted to rein in the oft-critiqued PBM industry by passing a law that allowed the state to regulate the companies to protect consumers and ...

Health-care companies were more or less flat as the sector's 2024 fall from grace appeared to carry through to the New Year. Shares of CVS Health, UnitedHealth Group and Cigna, owners of the leading ...